BioCentury
ARTICLE | Clinical News

BL-5010 regulatory update

September 19, 2011 7:00 AM UTC

BioLineRx said it received European confirmation that BL-5010 for the non-surgical removal of benign skin lesions will be classified as a class IIa medical device. BioLineRx said the classification "c...